Rubella Symptoms
Rubella is characterized by nonspecific signs and symptoms including transient erythematous and sometimes pruritic rash, postauricular or suboccipital lymphadenopathy, arthralgia, and low-grade fever. 1
Primary Clinical Manifestations
- Rash: Erythematous, maculopapular rash that classically begins on the face, spreads cephalocaudally, becomes generalized within 24 hours, and disappears within 3 days 2
- Lymphadenopathy: Primarily affects postauricular and suboccipital lymph nodes 1
- Fever: Low-grade fever is common 1
- Joint symptoms: Transient polyarthralgia or polyarthritis, particularly common among adult women (up to 70% of cases) 1
Important Clinical Considerations
- Subclinical infection: 25-50% of rubella infections are subclinical with no apparent symptoms 1
- Incubation period: Ranges from 12 to 23 days 1
- Contagious period: Patients are most contagious when the rash first appears, but the period of maximal communicability extends from a few days before to 7 days after rash onset 1
- Differential diagnosis: Clinically similar exanthematous illnesses are caused by parvovirus, adenoviruses, and enteroviruses 1
Complications
- Arthritis: More common in adults, especially women 1
- Central nervous system complications: Encephalitis occurs at a rate of 1 per 6,000 cases, more likely to affect adults 1
- Thrombocytopenia: Occurs at a rate of 1 per 3,000 cases, more likely to affect children 1
Congenital Rubella Syndrome (CRS)
The most serious consequence of rubella is infection during pregnancy, which can lead to:
- Pregnancy complications: Miscarriages, stillbirths, and fetal anomalies, especially during the first trimester 1
- Classic triad of congenital defects:
- Other CRS manifestations:
Clinical Pitfalls and Caveats
- Diagnostic challenges: Clinical diagnosis of rubella is unreliable due to its variable presentation and similarity to other exanthematous illnesses 1
- Laboratory confirmation: The only reliable evidence of previous rubella infection is the presence of serum rubella IgG antibody 1
- Risk assessment in pregnancy: The risk of congenital defects is highest (up to 85%) when infection occurs during the first 8 weeks of gestation 1
- Subclinical maternal infection: Even inapparent (subclinical) maternal rubella infection can cause congenital malformations 1